Lucid Diagnostics (LUCD) Other Non-Current Liabilities (2023 - 2025)
Lucid Diagnostics (LUCD) posted Other Non-Current Liabilities of $24.0 million for Q4 2025, up 7.62% on a QoQ basis from $22.3 million in Q3 2025, and up 29.03% year-over-year from $18.6 million in Q4 2024.
Lucid Diagnostics (LUCD) Other Non-Current Liabilities (2023 - 2025) Analysis & Trends
Lucid Diagnostics' Other Non-Current Liabilities history runs 3 years deep, the most recent figure standing at $24.0 million for Q4 2025.
- Quarterly Other Non-Current Liabilities rose 29.03% year-over-year to $24.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $24.0 million (up 29.03% YoY) and the FY2025 annual result came in at $24.0 million, up 29.03% from the prior year.
- Other Non-Current Liabilities was $24.0 million for Q4 2025 at Lucid Diagnostics, up from $22.3 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $32.8 million in Q1 2025 and bottomed at $10.2 million in Q3 2024.
- A 3-year average of $17.5 million and a median of $14.2 million in 2023 frame the typical range for Other Non-Current Liabilities.
- Annual changes were most pronounced in 2024 — Other Non-Current Liabilities slipped 29.61% — and 2025, when it jumped 149.62%.
- Lucid Diagnostics' Other Non-Current Liabilities stood at $14.0 million in 2023, then soared by 33.33% to $18.6 million in 2024, then increased by 29.03% to $24.0 million in 2025.
- Business Quant data shows LUCD's Other Non-Current Liabilities at $24.0 million in Q4 2025, $22.3 million in Q3 2025, and $25.3 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.89 Bn | 173.59 Bn | 6.27 Bn |
| 2 | Stryker | 127.82 Bn | 124.94 Bn | 3.81 Bn |
| 3 | Medtronic | 107.49 Bn | 98.27 Bn | 6.41 Bn |
| 4 | Boston Scientific | 67.24 Bn | 65.78 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.02 Bn | 44.34 Bn | 1.29 Bn |
| 6 | Dexcom | 28.25 Bn | 27.14 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.17 Bn | 25.89 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.72 Bn | 26.14 Bn | - |
| 9 | Koninklijke Philips | 25.31 Bn | 22.19 Bn | 2.07 Bn |
| 10 | Lucid Diagnostics | 127.24 Mn | 99.36 Mn | -325,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 24.00 Mn |
| Sep 30, 2025 | 22.30 Mn |
| Jun 30, 2025 | 25.30 Mn |
| Mar 31, 2025 | 32.80 Mn |
| Dec 31, 2024 | 18.60 Mn |
| Sep 30, 2024 | 10.20 Mn |
| Jun 30, 2024 | 11.20 Mn |
| Mar 31, 2024 | 13.14 Mn |
| Dec 31, 2023 | 13.95 Mn |
| Sep 30, 2023 | 14.49 Mn |
| Jun 30, 2023 | 11.61 Mn |
| Mar 31, 2023 | 11.90 Mn |